See All Slides - tctmd.com

Slides

Presentation TCT 2013

All Novel Agents are Preferred to Warfarin

Presenter: Michael Ezekowitz

October 29, 2013

Presentation TCT 2013

Silent Atrial Fibrillation: An Under-Appreciated Threat

Presenter: Taya Glotzer

October 29, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: A Symptomatic HCM Patient Without Resting Obstruction

Presenter: Morton Kern

October 29, 2013

Presentation TCT 2013

How Did I Treat?(2)

Presenter: Andreas Baumbach

October 29, 2013

Presentation

Treatment Options in Calcified Peripheral Vessels

Presenter: William Gray

October 29, 2013

Presentation

Coronary Calcification: Insights from Angiography, IVUS, and OCT

Presenter: Gary Mintz

October 29, 2013

Presentation TCT 2013

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Presenter: Martin Leon

October 29, 2013

Presentation TCT 2013

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presenter: Ted Feldman

October 29, 2013

Presentation TCT 2013

Vascular and Bleeding Complications

Presenter: James Hermiller Jr

October 29, 2013

Advertisement

Slides

All Novel Agents are Preferred to Warfarin

Silent Atrial Fibrillation: An Under-Appreciated Threat

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Case Presentation and Topic Review: A Symptomatic HCM Patient Without Resting Obstruction

How Did I Treat?(2)

Treatment Options in Calcified Peripheral Vessels

Coronary Calcification: Insights from Angiography, IVUS, and OCT

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Vascular and Bleeding Complications

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content